You Are Here: Home » Healthcare » Biotech PR

Data breach PR: How to survive your worst nightmare

There are two kinds of companies in this world: Those that have experienced a data breach, and those that will at some point in the future. At least that’s how seasoned cybersecurity experts approach risk assessment and mitigation plans. From a public-relations standpoint, once internal – or external – parties discover a data breach, a company’s immediate reaction will set the tone of the reportage. It’s a ...

Read more

2015 FDA Social Media Guidelines to Bring More Clarity?

Recently, the FDA released a list of approximately 100 items of draft guidance it plans to issue or update in 2015. On the list are a few guidelines pertaining to social media, which pleases many of us in PR who have been waiting (somewhat) patiently for direction over the past few years. As we wait, we thought we’d take a moment to address a few of the highlights we can expect this year. Of particular inte ...

Read more

Innovation Hits the Diagnostic Market

2015 will bring major changes to the diagnostic industry. From cholesterol screening to testing for cancer, we’ve entered a new era in how to test and monitor disease. Over the past couple of years, we’ve seen a boom in diagnostics, as the science behind genetic and single-drop blood testing has finally reached the market. There are, of course, many ways to screen for disease – from biomarkers to blood test ...

Read more

Big Data Takes Big Steps into Healthcare – Part I

There is a coming explosion in healthcare big data. Why? The big data analytics market swelled to $18.6 billion in 2013 - a whopping 58 percent growth from the previous year.[i] And this data behemoth isn’t standing still. Its economic foot print will grow to $50 billion by 2017.[ii] Dollar signs that big means there is an unfathomable amount of data to be analyzed. And tons of it is being generated by the ...

Read more

Podcast: Catching up with Cathy Arnst!

We recently spoke with industry veteran Cathy Arnst, who has been covering some of the most exciting progress in the science and medicine industry for more than two decades. Cathy recently joined Xconomy, a business news Website covering the innovation economy in Boston, San Francisco, San Diego, Seattle and Detroit.  Prior to writing for Xconomy, Cathy’s talented work graced the pages of Busines ...

Read more

8 Tips for Producing Compelling Patient Videos

In today’s digital world, video has become a powerful way to share and consume information. According to a Forrester report, “Optimizing video content is by far the easiest way to get a first-page organic ranking on Google. Having a video on your homepage can increase your ranking by 50x.” A broad spectrum of Schwartz MSL’s clients are working with our digital production team to crea ...

Read more

Cerulean Pharma and Six Other Boston Area Firms Named to FierceBiotech’s Fierce 15

Today FierceBiotech came out with its annual Fierce 15 list of innovative life sciences companies. We're pleased to congratulate Schwartz client Cerulean Pharma, a leader in designing and developing tumor-targeted nanopharmaceuticals, on their inclusion on the list.John Carroll, the publication's editor-in-chief, notes: "Making it today means actually meeting that unmet medical need, moving the dial on ...

Read more

Schwartz Ranks in Top Ten for Independent PR Firms!

Spring has sprung and with it, so has O’Dwyer’s annual ranking of independent public relations firms across the industry. Once again, Schwartz Communications was named among the top 10 independent PR firms out of 152 firms nationwide.  Additionally, Schwartz is ranked sixth among the top firms specializing in technology and healthcare respectively. Schwartz is proud to be ranked and recogni ...

Read more

Eli Lilly Takes Up Blogging

Pharma, biotech and medical device companies aren't terribly cowboy when it comes to corporate communications. I'd describe the general mindset as not so much "why wouldn't I share this information?" as "how does disclosing this information help me?"It's not that they don't want to market their companies, their therapies and their expertise, because they do. But on a day-to-day basis, th ...

Read more

Video Moves Beyond Consumer Healthcare PR to Technology, Life Sciences Communications

The Schwartz Digital team has been busy as of late creating videos and podcasts for our healthcare clients. It's great that these services have been so well received--I personally think it's indicative of widespread understanding among the types of companies Schwartz represents that there's way more to telling a story than issuing a press release and getting covered in BioWorld or Medical Device Daily. (Not ...

Read more

5 Reasons Why Your B2B Biotech Company Should Blog

Biotech companies have been slow to take advantage of blogging to communicate with their core audiences, but it's my impression that this situation is finally changing. Some of the interest I've been seeing among entrepreneurial life sciences companies is driven by an understanding of how blogging supports search engine optimization (SEO) efforts. There are more benefits to blogging than SEO, though, so her ...

Read more

Healthcare PR: BioImagene’s Build to USCAP

Say what you will about the effectiveness of conferences in the marketing mix--there are still a lot of shows that companies feel they have to attend in order to see and be seen. In the case of Schwartz client BioImagene, that conference is the annual meeting of the U.S. & Canadian Academy of Pathology (USCAP).BioImagene is one of the companies that dominate USCAP and their PR team is working overtime t ...

Read more